Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C

被引:67
作者
Li, F
Wang, F
Haraldson, K
Protopopov, A
Duh, FM
Geil, L
Kuzmin, I
Minna, JD
Stanbridge, E
Braga, E
Kashuba, VI
Klein, G
Lerman, MI
Zabarovsky, ER
机构
[1] Karolinska Inst, Microbiol & Tumor Biol Ctr, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden
[2] NCI, Ctr Canc Res, Lab Immunobiol, Canc Causing Genes Sect, Frederick, MD USA
[3] SAIC Frederick Inc, Basic Res Program, Frederick, MD USA
[4] Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol, Dallas, TX USA
[5] Univ Calif Irvine, Coll Med, Dept Microbiol & Mol Genet, Irvine, CA USA
[6] Russian State Genet Ctr, Moscow, Russia
[7] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine
[8] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia
关键词
D O I
10.1158/0008-5472.CAN-03-3869
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Initial analysis identified the NPRL2/G21 gene located in 3p21.3C, the lung cancer region, as a strong candidate tumor suppressor gene. Here we provide additional evidence of the tumor suppressor function of NPRL2/G21. The gene has highly conserved homologs/orthologs ranging from yeast to humans. The yeast ortholog, NPR2, shows three highly conserved regions with 32 to 36% identity over the whole length. By sequence analysis, the main product of NPRL2/G21 encodes a soluble protein that has a bipartite nuclear localization signal, a protein-binding domain, similarity to the MutS core domain, and a newly identified nitrogen permease regulator 2 domain with unknown function. The gene is highly expressed in many tissues. We report inactivating mutations in a variety of tumors and cancer cell lines, growth suppression of tumor cells with tet-controlled NPRL2/G21 transgenes on plastic Petri dishes, and suppression of tumor formation in SCID mice. Screening of 7 renal, 5 lung, and 7 cervical carcinoma cell lines showed homozygous deletions in the 3' end of NPRL2 in 2 renal, 3 lung, and I cervical (HeLa) cell line. Deletions in the 3' part of NPRL2 could result in improper splicing, leading to the loss of the 1.8 kb functional NPRL2 mRNA. We speculate that the NPRL2/G21 nuclear protein may be involved in mismatch repair, cell cycle checkpoint signaling, and activation of apoptotic pathway(s). The yeast NPR2 was shown to be a target of cisplatin, suggesting that the human NPRL2/G21 may play a similar role. At least two homozygous deletions of NPRL2/G21 were detected in 6 tumor biopsies from various locations and with microsatellite instability. This study, together with previously obtained results, indicates that NPRL2 is a multiple tumor suppressor gene.
引用
收藏
页码:6438 / 6443
页数:6
相关论文
共 25 条
  • [1] Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma
    Alimov, A
    Kost-Alimova, M
    Liu, J
    Li, CD
    Bergerheim, U
    Imreh, S
    Klein, G
    Zabarovsky, ER
    [J]. ONCOGENE, 2000, 19 (11) : 1392 - 1399
  • [2] Critical tumor-suppressor gene regions on chromosome 3p in major human epithelial malignancies: Allelotyping and quantitative real-time PCR
    Braga, E
    Senchenko, V
    Bazov, I
    Loginov, W
    Liu, J
    Ermilova, V
    Kazubskaya, T
    Garkavtseva, R
    Mazurenko, N
    Kisseljov, F
    Lerman, MI
    Klein, G
    Kisselev, L
    Zabarovsky, ER
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 100 (05) : 534 - 541
  • [3] Comparative allelotyping of the short arm of human chromosome 3 in epithelial tumors of four different types
    Braga, E
    Pugacheva, E
    Bazov, I
    Ermilova, V
    Kazubskaya, T
    Mazurenko, N
    Kisseljov, F
    Liu, J
    Garkavtseva, R
    Zabarovsky, E
    Kisselev, L
    [J]. FEBS LETTERS, 1999, 454 (03) : 215 - 219
  • [4] Membrane sequestration of the signal transduction protein GlnK by the ammonium transporter AmtB
    Coutts, G
    Thomas, G
    Blakey, D
    Merrick, M
    [J]. EMBO JOURNAL, 2002, 21 (04) : 536 - 545
  • [5] The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis
    Dreijerink, K
    Braga, E
    Kuzmin, I
    Geil, L
    Duh, FM
    Angeloni, D
    Zbar, B
    Lerman, MI
    Stanbridge, EJ
    Minna, JD
    Protopopov, A
    Li, JF
    Kashuba, V
    Klein, G
    Zabarovsky, ER
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (13) : 7504 - 7509
  • [6] A combined approach of conventional and molecular cytogenetics for detailed karyotypic analysis of the small cell lung carcinoma cell line U2020
    Heppell-Parton, AC
    Nacheva, E
    Carter, NP
    Rabbitts, PH
    [J]. CANCER GENETICS AND CYTOGENETICS, 1999, 108 (02) : 110 - 119
  • [7] Search for unknown tumor-antagonizing genes
    Imreh, S
    Klein, G
    Zabarovsky, ER
    [J]. GENES CHROMOSOMES & CANCER, 2003, 38 (04) : 307 - 321
  • [8] Ji L, 2002, CANCER RES, V62, P2715
  • [9] RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies
    Kashuba, VI
    Li, JF
    Wang, FL
    Senchenko, VN
    Protopopov, A
    Malyukova, A
    Kutsenko, AS
    Kadyrova, E
    Zabarovska, VI
    Muravenko, OV
    Zelenin, AV
    Kisselev, LL
    Kuzmin, I
    Minna, JD
    Winberg, G
    Ernberg, I
    Braga, E
    Lerman, MI
    Klein, G
    Zabarovsky, ER
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (14) : 4906 - 4911
  • [10] KOK K, 1994, CANCER RES, V54, P4183